Microarray-based identification of aminopeptidase N target genes in keratinocyte conditioned medium-stimulated dermal fibroblasts

Journal of Cellular Biochemistry

Volumn 113, Issue 3, 2012, Pages 1061-1068

  Lai, Amy ^a   Ghaffari, Abdi ^a   Li, Yunyuan ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aminopeptidase N; Contraction; Extracellular Matrix; Fibronectin; Matrix Metalloproteinase; Tenascin C

Indexed keywords

ALPHA CATENIN; ALPHA1 CATENIN; ALPHA1 INTEGRIN; ALPHA3 CATENIN; BESTATIN; COLLAGEN GEL; FIBRONECTIN; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MICROSOMAL AMINOPEPTIDASE; PROTEOGLYCAN; SPARC OSTEONECTIN CWCV AND KAZAL LIKE DOMAINS PROTEOGLYCAN; STROMELYSIN; TENASCIN; UNCLASSIFIED DRUG; VERSICAN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

ANTIGENS, CD13; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DERMIS; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION PROFILING; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; TENASCIN;

EID: 84863273214     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23438     Document Type: Article

References (48)

1. Baldin V. 2000. 14-3-3 proteins and growth control. Prog Cell Cycle Res 4: 49-60.
2. Betz P, Nerlich A, Tubel J, Penning R, Eisenmenger W. 1993. Localization of tenascin in human skin wounds-An immunohistochemical study. Int J Legal Med 105: 325-328. (Pubitemid 23156594)
3. Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH. 2001. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97: 652-659. (Pubitemid 32113397)
4. Craig RD. 1975. Collagen biosynthesis in normal human skin, normal and hypertrophic scar and keloid. Eur J Clin Invest 5: 69-74.
5. Danziger RS. 2008. Aminopeptidase N in arterial hypertension. Heart Fail Rev 13: 293-298.
6. Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F. 2005. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. J Pharmacol Exp Ther 314: 1169-1176. (Pubitemid 41205981)
7. Fu H, Subramanian RR, Masters SC. 2000. 14-3-3proteins: Structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647.
8. Fujii H, Nakajima M, Aoyagi T, Tsuruo T. 1996. Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors. Biol Pharm Bull 19: 6-10. (Pubitemid 26060548)
9. Ghaffari A, Li Y, Karami A, Ghaffari M, Tredget EE, Ghahary A. 2006. Fibroblast extracellular matrix gene expression in response to keratinocytereleasable stratifin. J Cell Biochem 98: 383-393.
10. Ghaffari A, Li Y, Kilani RT, Ghahary A. 2010. 14-3-3{sigma} associates with cell surface aminopeptidase N in the regulation of matrix metalloproteinase- 1. J Cell Sci 123: 2996-3005.
11. Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget EE, Taghi KR, Li L, Zheng J, Karami A, Keller BO, Weinfeld M. 2004. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122: 1188-1197. (Pubitemid 38651094)
12. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. 2005. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 124: 170-177. (Pubitemid 40100966)
13. Giros B, Gros C, Solhonne B, Schwartz JC. 1986. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Mol Pharmacol 29: 281-287. (Pubitemid 16127007)
14. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. 2001. Alphasmooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12: 2730-2741. (Pubitemid 33051938)
15. Hoffmann T, Faust J, Neubert K, Ansorge S. 1993. Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett 336(1): 61-64. (Pubitemid 23362003)
16. Kanayama N, Kajiwara Y, Goto J, el ME, Maehara K, Andou K, Terao T. 1995. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57: 129-134.
17. Kischer CW, Wagner HN, Jr., Pindur J, Holubec H, Jones M, Ulreich JB, Scuderi P. 1989. Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect Tissue Res 23: 279-288.
18. Lai A, Ghaffari A, Ghahary A. 2010. Inhibitory effect of anti-aminopeptidase N/CD13 antibodies on fibroblast migration. Mol Cell Biochem 343(1-2): 191-199.
19. Lai A, Ghaffari A, Li Y, Ghahary A. 2011. Paracrine regulation of fibroblast aminopeptidase N/CD13 expression by keratinocyte-releasable stratifin. J Cell Physiol 226(12): 3114-3120.
20. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A. 2005. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogenactivated protein kinase activation. J Invest Dermatol 125: 230-238. (Pubitemid 41648154)
21. Latijnhouwers MA, Bergers M, Van Bergen BH, Spruijt KI, Andriessen MP, Schalkwijk J. 1996. Tenascin expression during wound healing in human skin. J Pathol 178: 30-35. (Pubitemid 26053394)
22. Lenga Y, Koh A, Perera AS, McCulloch CA, Sodek J, Zohar R. 2008. Osteopontin expression is required for myofibroblast differentiation. Circ Res 102: 319-327. (Pubitemid 351271652)
23. Mackie EJ, Halfter W, Liverani D. 1988. Induction of tenascin in healing wounds. J Cell Biol 107: 2757-2767. (Pubitemid 19019409)
24. Mahajan VB, Wei C, McDonnell PJ III. 2002. Microarray analysis of corneal fibroblast gene expression after interleukin-1 treatment. Invest Ophthalmol Vis Sci 43: 2143-2151. (Pubitemid 34700640)
25. Matsas R, Stephenson SL, Hryszko J, Kenny AJ, Turner AJ. 1985. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N. Biochem J 231: 445-449.
26. Matsumoto S, Kobayashi T, Katoh M, Saito S, Ikeda Y, Kobori M, Masuho Y, Watanabe T. 1998. Expression and localization of matrix metalloproteinase- 12 in the aorta of cholesterol-fed rabbits: Relationship to lesion development. Am J Pathol 153: 109-119. (Pubitemid 28317513)
27. Menozzi D, Gu ZF, Maton PN, Bunnett NW. 1991a. Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells. Am J Physiol 261: G476-G484.
28. Menozzi D, Gu ZF, Maton PN, Bunnett NW. 1991b. Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells. Am J Physiol 261: G476-G484.
29. Midwood KS, Schwarzbauer JE. 2002. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol Biol Cell 13: 3601-3613. (Pubitemid 35191378)
30. Midwood KS, Valenick LV, Hsia HC, Schwarzbauer JE. 2004. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol Biol Cell 15: 5670-5677. (Pubitemid 39564757)
31. Mina-Osorio P. 2008. The moonlighting enzyme CD13: Old and new functions to target. Trends Mol Med 14: 361-371.
32. Mina-Osorio P, Shapiro LH, Ortega E. 2006. CD13 in cell adhesion: Aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells. J Leukoc Biol 79: 719-730. (Pubitemid 44835604)
33. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van DJ. 2007a. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110: 37-44. (Pubitemid 47026816)
34. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van DJ. 2007b. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110: 37-44. (Pubitemid 47026816)
35. Rahmani-Neishaboor E, Yau FM, Jalili R, Kilani RT, Ghahary A. 2010. Improvement of hypertrophic scarring by using topical anti-fibrogenic/ anti-inflammatory factors in a rabbit ear model. Wound Repair Regen 18(4): 401-408.
36. Reinhold D, Biton A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, Tager M, Ansorge S, Brocke S. 2006. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Int Immunopharmacol 6(13- 14): 1935-1942. (Pubitemid 44855698)
37. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I. 1993. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143. (Pubitemid 23137011)
38. Santos AN, Langner J, Herrmann M, Riemann D. 2000. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol 201: 22-32. (Pubitemid 30337705)
39. Shapiro SD. 1998. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 10: 602-608. (Pubitemid 28477018)
40. Shimizu T, Tani K, Hase K, Ogawa H, Huang L, Shinomiya F, Sone S. 2002. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 46: 2330-2338.
41. Trojanowska M, LeRoy EC, Eckes B, Krieg T. 1998. Pathogenesis of fibrosis: Type 1 collagen and the skin. J Mol Med 76: 266-274. (Pubitemid 28098712)
42. van Hemert MJ, Steensma HY, van Heusden GP. 2001. 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis. Bioessays 23: 936-946. (Pubitemid 32972693)
43. Wong JW, Gallant-Behm C, Wiebe C, Mak K, Hart DA, Larjava H, Hakkinen L. 2009. Wound healing in oral mucosa results in reduced scar formation as compared with skin: Evidence from the red Duroc pig model and humans. Wound Repair Regen 17: 717-729.
44. Woodside KJ, Hu M, Burke A, Murakami M, Pounds LL, Killewich LA, Daller JA, Hunter GC. 2003. Morphologic characteristics of varicose veins: Possible role of metalloproteinases. J Vasc Surg 38: 162-169. (Pubitemid 41123304)
45. Wulfaenger J, Niedling S, Riemann D, Seliger B. 2008. Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion. Mol Membr Biol 25: 72-82.
46. Xu Y, Wellner D, Scheinberg DA. 1995a. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem Biophys Res Commun 208: 664-674.
47. Xu Y, Wellner D, Scheinberg DA. 1995b. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem Biophys Res Commun 208: 664-674.
48. Zhang HY, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. 1996. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 148: 527-537. (Pubitemid 26056737)